|Awarded On||February 21, 2018|
|Title||Blood-based biomarkers for the early detection of pancreatic cancer|
|Award Mechanism||Individual Investigator Research Awards for Prevention and Early Detection|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Ann Killary|
Pancreatic cancer is the third leading cause of cancer related deaths by organ type and is predicted to be the second leading cause of cancer deaths by the year 2030. Due to lack of clinically detectable symptoms, most cases are diagnosed late with locally advanced or metastatic disease. If pancreatic cancer is detected early (less than/equal to stage IIB), surgical resection results in substantially improved survival compared to advanced disease (greater than/equal to stage III). Identification of biomarkers for the early detection of pancreatic cancer is a critically urgent need because currently there are no clinically validated biomarkers for the detection of resectable early stage pancr...